Biodexa Pharmaceuticals PLC Stock Ownership - Who owns Biodexa Pharmaceuticals?

Insider buying vs selling

Have Biodexa Pharmaceuticals PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BDRX insiders and whales buy or sell their stock.

BDRX Shareholders

What type of owners hold Biodexa Pharmaceuticals PLC stock?
Renaissance Technologies LLC0.36%53,016$4.51kInstitution
Virtu Financial LLC0.32%47,289$4.02kInstitution
Millennium Management LLC0.25%36,725$3.12kInstitution
Cvi Holdings LLC0.21%30,611$2.60kInstitution
Kingsview Wealth Management LLC0.11%16,647$1.41kInstitution
Morgan Stanley0.01%1,368$116.28Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

BDRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ONCS1.11%98.89%Net Selling
NBY0.25%99.75%Net Selling

Biodexa Pharmaceuticals Stock Ownership FAQ

Who owns Biodexa Pharmaceuticals?

Biodexa Pharmaceuticals (NASDAQ: BDRX) is owned by 1.27% institutional shareholders, 0.00% Biodexa Pharmaceuticals insiders, and 98.73% retail investors. Renaissance Technologies LLC is the largest individual Biodexa Pharmaceuticals shareholder, owning 53,016.00 shares representing 0.36% of the company. Renaissance Technologies LLC's Biodexa Pharmaceuticals shares are currently valued at $4.61k.

If you're new to stock investing, here's how to buy Biodexa Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.